Friedreich's ataxia echocardiography and ultrasound: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Friedreich's ataxia}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== ==Echocardiography/Ultrasound== There are no echocardiography/ultrasound findings associated with [di...") |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Echocardiography | ==Echocardiography== | ||
Echocardiography may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include: | |||
*varying degrees of septal hypertrophy in 81%, left ventricular free wall hypertrophy in 61%, and a slight reduction of left ventricular internal dimension in 57% of the cases. Asymmetric septal hypertrophy (ASH) with a septal/left ventricular free wall ratio of over 1.3 was found in 29% of the cases, and systolic anterior motion (SAM) of the mitral valve in three patients. Two other patients showed evidence of a different type of cardiomyopathy with marked symmetric left ventricular hypertrophy and marked left ventricular enlargement. | |||
Echocardiography | |||
* | |||
==References== | ==References== | ||
Revision as of 14:11, 30 April 2019
|
Friedreich's ataxia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Friedreich's ataxia echocardiography and ultrasound On the Web |
|
American Roentgen Ray Society Images of Friedreich's ataxia echocardiography and ultrasound |
|
Friedreich's ataxia echocardiography and ultrasound in the news |
|
Blogs on Friedreich's ataxia echocardiography and ultrasound |
|
Risk calculators and risk factors for Friedreich's ataxia echocardiography and ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Echocardiography
Echocardiography may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include:
- varying degrees of septal hypertrophy in 81%, left ventricular free wall hypertrophy in 61%, and a slight reduction of left ventricular internal dimension in 57% of the cases. Asymmetric septal hypertrophy (ASH) with a septal/left ventricular free wall ratio of over 1.3 was found in 29% of the cases, and systolic anterior motion (SAM) of the mitral valve in three patients. Two other patients showed evidence of a different type of cardiomyopathy with marked symmetric left ventricular hypertrophy and marked left ventricular enlargement.